Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,286,000 | 4,873,000 | 11,845,000 | 11,549,000 | 4,622,000 |
| Depreciation Amortization | 8,386,000 | 8,698,000 | 8,467,000 | 8,521,000 | 6,471,000 |
| Income taxes - deferred | -1,449,000 | -2,889,000 | -1,931,000 | -898,000 | -2,325,000 |
| Accounts receivable | 207,000 | 66,000 | -1,455,000 | -1,321,000 | -929,000 |
| Accounts payable and accrued liabilities | 177,000 | 3,840,000 | 1,769,000 | 1,719,000 | 1,514,000 |
| Other Working Capital | -2,845,000 | 2,588,000 | -244,000 | -1,444,000 | 969,000 |
| Other Operating Activity | 10,044,000 | 5,663,000 | 6,492,000 | 4,651,000 | 7,266,000 |
| Operating Cash Flow | $18,806,000 | $22,839,000 | $24,943,000 | $22,777,000 | $17,588,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -974,000 | -777,000 | -695,000 | -787,000 | -798,000 |
| Net Acquisitions | -20,517,000 | -1,223,000 | -794,000 | -1,902,000 | -39,610,000 |
| Purchase Of Investment | -73,000 | -77,000 | -1,438,000 | -119,000 | -61,000 |
| Sale Of Investment | 555,000 | 55,000 | 1,530,000 | 98,000 | 1,525,000 |
| Other Investing Activity | 189,000 | 13,000 | 774,000 | 366,000 | 1,387,000 |
| Investing Cash Flow | $-20,820,000 | $-2,009,000 | $-623,000 | $-2,344,000 | $-37,557,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,008,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 16,963,000 | 0 | 2,000,000 | 1,000,000 | 3,000,000 |
| Debt Repayment | -9,613,000 | -4,149,000 | -14,433,000 | -9,414,000 | -5,683,000 |
| Common Stock Issued | 214,000 | 180,000 | 262,000 | 244,000 | 209,000 |
| Common Stock Repurchased | -1,708,000 | -1,972,000 | -1,487,000 | -934,000 | -978,000 |
| Dividend Paid | -11,025,000 | -10,539,000 | -10,043,000 | -9,261,000 | -7,716,000 |
| Other Financing Activity | -5,050,000 | -742,000 | -1,102,000 | -674,000 | -333,000 |
| Financing Cash Flow | $-5,211,000 | $-17,222,000 | $-24,803,000 | $-19,039,000 | $-11,501,000 |
| Exchange Rate Effect | -65,000 | 5,000 | -62,000 | -97,000 | -5,000 |
| Beginning Cash Position | 12,814,000 | 9,201,000 | 9,746,000 | 8,449,000 | 39,924,000 |
| End Cash Position | 5,524,000 | 12,814,000 | 9,201,000 | 9,746,000 | 8,449,000 |
| Net Cash Flow | $-7,290,000 | $3,613,000 | $-545,000 | $1,297,000 | $-31,475,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,806,000 | 22,839,000 | 24,943,000 | 22,777,000 | 17,588,000 |
| Capital Expenditure | -974,000 | -777,000 | -695,000 | -787,000 | -798,000 |
| Free Cash Flow | 17,832,000 | 22,062,000 | 24,248,000 | 21,990,000 | 16,790,000 |